Victory Capital Management
KDNY

Victory Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Victory Capital Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-991,014
Closed -$22.9M – 2640
2023
Q1 		$22.9M Sell
991,014
-172,231
-15% -$4.11M 0.03% 722
2022
Q4 		$30.5M Buy
1,163,245
+136,182
+13% +$3.02M 0.04% 626
2022
Q3 		$20.2M Buy
+1,027,063
New +$20.6M 0.02% 811
2020
Q2 		– Sell
-3,832
Closed -$52K – 3479
2020
Q1 		$52K Buy
+3,832
New +$45.3K ﹤0.01% 2752
2019
Q4 		– Sell
-1,614
Closed -$9K – 3464
2019
Q3 		$9K Buy
+1,614
New +$10.7K ﹤0.01% 3311
2019
Q2 		– Sell
-242
Closed -$5K – 1870
2019
Q1 		$5K Hold
242
– – ﹤0.01% 1770
2018
Q4 		$3K Hold
242
– – ﹤0.01% 1776
2018
Q3 		$9K Buy
242
+32
+15% +$1.03K ﹤0.01% 1781
2018
Q2 		$7K Hold
210
– – ﹤0.01% 1817
2018
Q1 		$10K Hold
210
– – ﹤0.01% 1808
2017
Q4 		$8K Hold
210
– – ﹤0.01% 1806
2017
Q3 		$11K Hold
210
– – ﹤0.01% 1797
2017
Q2 		$12K Buy
210
+3
+1% +$151 ﹤0.01% 1794
2017
Q1 		$11K Hold
207
– – ﹤0.01% 1787
2016
Q4 		$12K Buy
207
+12
+6% +$726 ﹤0.01% 1778
2016
Q3 		$12K Buy
195
+13
+7% +$919 ﹤0.01% 1769
2016
Q2 		$10K Buy
182
+36
+25% +$2.19K ﹤0.01% 1623
2016
Q1 		$9K Buy
+146
New +$11.8K ﹤0.01% 1652

Other funds holding KDNY

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Victory Capital Management's KDNY Position: Q2 2023 in Review

Victory Capital Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2023, closing a stake of 991,014 shares — an estimated $22.9M sold.

Victory Capital Management first reported a position in KDNY in Q1 2016 and held it in 18 quarters. The position peaked at $30.5M in Q4 2022. 185 funds tracked by Wall St. Rank hold KDNY as of Q2 2023.

  • Victory Capital Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Victory Capital Management sold 991,014 Chinook Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $22.9M.
  • Victory Capital Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2016 and held it in 18 quarters.
  • Victory Capital Management's Chinook Therapeutics, Inc. Common Stock position peaked at $30.5M in Q4 2022.
  • 185 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Victory Capital Management's 13F filing for Q2 2023, filed 27 Jul 2023.